Obstetrics & Gynaecology
Breech Presentation Management
Management of breech at term — ECV, planned CS, and criteria for vaginal breech birth
Source: RCOG GTG 20b 2017
Step 1 of ~10
info
Breech Presentation
Breech presentation at term: 3–4% of term pregnancies. Confirmed by USS at 36 weeks. Types: Frank (extended legs — most common), Complete (flexed), Footling (one or both feet presenting). All should be offered ECV if no contraindications.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Hydroxyprogesterone Caproate / Progesterone (Preterm Birth Prevention) · Progestogen (Preterm Birth Prevention)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Clotrimazole · Topical / vaginal imidazole antifungal
- Estradiol (HRT — Hormone Replacement Therapy) · Oestrogen Replacement Therapy
- Lorazepam (Elderly — Short-Term Use) · Benzodiazepine
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21
Decision support only. Always apply local guidelines and clinical judgement.